Skip to main content
Fig. 4 | BMC Oral Health

Fig. 4

From: Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma

Fig. 4

The expression profiles of 75 immune-related signatures between high and low cGAS-STING clusters. a Heatmap of the expression of immune signatures. b The expression level of immune checkpoint molecules. All P values for significance (< 0.05) represent comparisons via multiple t tests with FDR < 0.05. *P value < 0.05, **P value < 0.01, ***P value < 0.001, and ****P value < 0.0001

Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us